Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Imsight Medical

Request full access

Develops artificial intelligence assisted medical imaging analysis tools

Sha Tin District, Hong KongFounded 2017Health Tech & Medtech

About Imsight Medical

Imsight Medical Technology, established in 2017, operates as a developer of artificial intelligence-based medical imaging analysis tools. The company was incubated at the Medical Image Analysis laboratory at The Chinese University of Hong Kong (CUHK) and founded by a group of professors and PhDs from the university. The founder, Chen Hao, was featured in the journal Nature in December 2020 to discuss the future of AI in medicine. The company's CEO for the Shenzhen Division is Zhang Hongwei, who brings 20 years of experience in the medical device industry. Since its inception, Imsight has secured multiple rounds of financing, including a Series B round in April 2020 led by Lenovo Capital and Incubator Group and China Merchants.

The firm's business model is centered on providing AI-powered software solutions to healthcare providers, primarily hospitals and diagnostic centers, on a B2B basis. Its technology is designed to integrate with existing clinical workflows, receiving imaging scans from various modalities for automated analysis. This addresses the challenges of increasing workloads, long reporting times, and diagnostic inconsistencies faced by radiologists and pathologists. The company's AI platform analyzes a vast database of medical scans to help clinicians identify diseases more efficiently. By automating the quantification of lesions and other visual signs, the software significantly reduces the time required for diagnosis and reporting.

Imsight's product portfolio includes several specialized tools for different diagnostic purposes. Lung-Sight provides automated lung nodule detection and analysis from CT images, generating reports within seconds. Another product, Cervical-Sight, is an AI screening system for cervical cancer that analyzes digitalized slide images from Pap smear tests to identify abnormal cells and classify them according to TBS guidelines. The system can process over 2,000 slides daily, serving as a second reader to alleviate the workload of physicians. The company also offers DR-Sight and Rib-Sight, among others, and provides co-creation opportunities to tailor solutions for specific client needs. These products are deployed in over 30 hospitals and screening centers, mainly in Hong Kong and the Greater Bay Area.

Source: Dealroom company data

At a glance

Status
Operational
Employees
6
Open positions
None listed
Dealroom signal
46.6/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Diagnostics, Hard Tech, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech, Machine Learning, Computer Vision
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jun 2018 $15M $61M China Merchants Capital —
SERIES A✓Equity / VC Mar 2018 $9.5M $38M Shenzhen Capital Group —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Imsight Medical website traffic

Latest recorded traffic for Imsight Medical is 100 monthly website visits, down 44.4% over the last three months. Imsight Medical's team grew 0% over the past year.

Latest monthly visits100 3-month web change-44.4% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Imsight Medical in the Sha Tin District ecosystem

Live from Dealroom

The Imsight Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇭🇰 Hong Kong66.7%
🇨🇳 China33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Imsight Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Imsight Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.